StockData

Yarrow Bioscience, Inc. (YARW) stock

YARWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/30102% above fair value
$14.35+0.14 (+0.99%)

Close on Nov 18, 2026Market cap $38.31MP/E –Yield –

Yarrow Bioscience price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Yarrow Bioscience's price to book ratio was 0.5× on Nov 11, 2026, against 0.2× a year earlier. Over the last 5 years it ranged from 0.1× to 1.0×, with a median of 0.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.5×+0.3
2025Dec 31, 20250.3×−0.5
2024Dec 31, 20240.8×+0.1
2023Dec 29, 20230.7×+0.5
2022Dec 30, 20220.2×−0.7
2021Dec 31, 20210.9×−4.4
2020Dec 31, 20205.4×+3.3
2019Dec 31, 20192.1×+1.4
2018Dec 31, 20180.7×–

More Yarrow Bioscience figures

See a number that looks wrong?